3,359 findings · Energy balance · published 2017+
- Energy balanceStrong
The discrepancy in energy expenditure between the metabolic ward and respiratory chamber was smaller than previously found in exercising men.
This suggests that exercise may significantly influence energy expenditure measurements.
Qualifies 2018 - Energy balanceStrong
Failure to reproduce previous results may be due to the lack of exercise, inclusion of women, or wider range of BMIs.
Understanding these factors can help in designing future studies on energy expenditure.
Qualifies 2018 - Energy balanceStrong
The historical view that 'a calorie is a calorie' is an oversimplification.
Practitioners should be cautious of oversimplified views on calorie intake.
Supports 2023 - Energy balanceStrong
The reanalysis of the randomized crossover trial did not support the carbohydrate-insulin model of obesity.
Practitioners should be cautious about claims supporting the carbohydrate-insulin model based on flawed analyses.
Refutes 2024 - Energy balanceStrong
The US food supply provides close to 4,000 calories a day per capita, an amount roughly twice the average need.
Practitioners should be aware of the excess caloric availability in the food supply.
Supports 2018 - Energy balanceStrong
Food and beverage companies encourage us to buy more and eat more.
Practitioners should consider the impact of marketing strategies on dietary choices.
Supports 2018 - Energy balanceStrong
Race was significantly associated with body fat reduction, indicating non-White participants gained more body fat compared to Whites.
Consideration of racial factors may be important in body fat reduction strategies.
Qualifies 2021 - Energy balanceStrong
There were no significant differences in serum TMAO, fasting glucose, fasting insulin, or vitamin B12 between vegan and omnivorous twins after 4 or 8 weeks.
Practitioners may consider that a healthy omnivorous diet can yield similar clinical outcomes as a vegan diet.
Refutes 2023 - Energy balanceStrong
Receiving e-messages had no effect on treatment adherence, with class attendance after 6 months showing an increase of +4.6% compared to matched controls (P=.31).
The intervention of sending e-messages did not improve adherence, suggesting that alternative methods may be needed.
Refutes 2018 - Energy balanceStrong
No significant differences were observed between the vegan and omnivorous diets for secondary outcomes of triglycerides or HDL-C.
The type of diet may not significantly affect triglycerides or HDL cholesterol levels.
Refutes 2023 - Energy balanceStrong
There was no significant difference in energy intake between values obtained by COCO and 24-hour recall for days when both methods were used (mean 2092, SD 1044 kcal versus mean 2030, SD 687 kcal, P=.70).
COCO Nutritionist may be a viable alternative to traditional dietary recall methods for assessing energy intake.
Supports 2021 - Energy balanceStrong
There were no significant differences between the methods for percent of energy from protein, carbohydrate, and fat (P=.27-.89).
COCO Nutritionist provides comparable macronutrient distribution data to traditional methods.
Supports 2021 - Energy balanceStrong
This first demonstration of a dietary assessment method using natural spoken language to map reported foods to food composition codes demonstrates a promising new approach to automate assessments of dietary intake.
The COCO Nutritionist app could simplify dietary assessments through automated technology.
Supports 2021 - Energy balanceStrong
Individuals in countries with low-income consume fewer fruits and vegetables and spend a greater proportion of their income on food compared to those in high-income countries.
Practitioners should focus on improving access to fruits and vegetables in low-income areas.
Supports 2020 - Energy balanceStrong
Even after bariatric surgery, patients may not lose the expected amount of weight or may experience weight regain.
Understand that bariatric surgery may not guarantee weight loss success and additional support may be needed.
Supports 2024 - Energy balanceStrong
The current care for people with obesity in Germany is inadequate and relies on non-reimbursed services.
Practitioners should advocate for better reimbursement policies to improve obesity care.
Supports 2024 - Energy balanceStrong
The metabolic phenotype of the people of Bangladesh is different from Caucasians.
Understanding these differences is crucial for effective obesity management strategies.
Supports 2024 - Energy balanceStrong
Obesity threatens to affect 30% of the world's population by 2030.
Health professionals should be aware of the rising obesity rates and their implications.
Supports 2024 - Energy balanceStrong
Barriers to treatment for obesity-related hypertension include obesity stigma, limited access to healthcare, and adherence problems.
Addressing stigma and improving access to care are crucial for effective management of obesity-related hypertension.
Supports 2025New - Energy balanceStrong
The prevalence of obesity has increased four-fold over the four preceding decades, with concomitantly rising rates of hypertension.
Healthcare providers should be aware of the significant rise in obesity and hypertension prevalence.
Supports 2025New - Energy balanceStrong
Sub-chronic administration of 0839 and 0833 reduced food intake and body weight in DIO mice and rats.
These compounds may help in managing weight in populations with diet-induced obesity.
Supports 2025New - Energy balanceStrong
No significant differences in efficacy and safety of the drugs were found between age groups.
Efficacy and safety of these drugs appear consistent, regardless of age.
Supports 2025New - Energy balanceStrong
Rates of obesity are projected to continue to increase, with severe obesity expected to be the most common body mass index category for women in the coming decade.
Practitioners should be aware of the increasing prevalence of obesity among women and its implications for health.
Supports 2025New - Energy balanceStrong
Adverse effects of tirzepatide are most often mild and well tolerated, with no significant impact on patients’ quality of life.
Tirzepatide may be a safe option for patients concerned about side effects.
Supports 2025New